Lilly Diabetes Donates 91 Scholarships to American Diabetes Association's Summer Camp Program - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Lilly Diabetes Donates 91 Scholarships to American Diabetes Association's Summer Camp Program

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 3
Lilly Diabetes announced its support for the American Diabetes Association's summer camp program for the seventh year in a row with a donation of $91,000 that will send 91 children to diabetes camp this summer. Since 2008, Lilly Diabetes has supported 531 children attending diabetes camps throughout the US, a scholarship donation totaling over half a million dollars.

Today, there are approximately 130 diabetes camps nationwide. The Association is the single largest operator of US camps for children with diabetes, with 40 camps offering 49 sessions in 25 states each summer. In the last decade, Lilly has donated more than $20 million in insulin and other diabetes medicines, educational materials, volunteers, scholarships, and motivational speakers, making it one of the largest supporters of diabetes camps in the country.

Camp scholarships are awarded by the Association based on financial need.

Source: Lilly Diabetes

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
21%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
8%
Regulatory compliance
42%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here